Related Experiment Video
Updated: Apr 7, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.6K
A Real-World Study on Medical Resource Consumption in Multidrug-Resistant Organism Infections Under the DRG Payment
Dongping Jiang1, Yuan Liu1, Sen Yang2
1Hospital Infection Management Department, Suining Central Hospital, Suining, Sichuan, 629000, People's Republic of China.
Risk Management and Healthcare Policy
|April 6, 2026
Summary
Multidrug-resistant organism (MDRO) infections significantly increase hospital length of stay and costs in China. Targeted control of high-incidence MDRO Diagnosis-Related Groups (DRG) is crucial for effective hospital cost management.
Area of Science:
- Healthcare Economics
- Infectious Diseases
- Hospital Management
Background:
- Diagnosis-Related Groups (DRG) is the primary payment model in China.
- Multidrug-resistant organism (MDRO) infections are rising, impacting patient outcomes and resource utilization.
- Understanding the economic burden of MDROs is vital for healthcare systems.
Purpose of the Study:
- To quantify the impact of MDRO infections on medical resource consumption in a Chinese tertiary hospital.
- To provide data for precise prevention and cost management strategies under the DRG system.
- To analyze resource consumption differences between MDRO-infected and non-infected patients.
Main Methods:
- Retrospective analysis of discharge data from January 2023 to December 2024.
- Comparison of resource consumption (LOS, costs) between MDRO-infected and non-infected patient groups.
- Stratification analysis of resource consumption by Diagnosis-Related Groups (DRG).
Main Results:
- MDRO infections led to significantly higher Time Consumption Index (TCI) and Cost Consumption Index (CCI) (P < 0.05).
- Carbapenem-resistant Gram-negative bacilli (CR-GNB) showed higher resource consumption than Methicillin-resistant Staphylococcus aureus (MRSA).
- In high-infection-rate DRGs, MDRO-infected patients had longer LOS and higher costs, with increased non-medical discharge and mortality.
Conclusions:
- MDRO infections substantially increase medical resource consumption and costs.
- Targeted control of high-incidence MDROs within specific DRGs is essential.
- Hospitals need to adapt strategies to manage MDROs effectively within the DRG payment model.
Keywords:
cost consumption indexdiagnosis-related groupshospitalization costslength of staymultidrug-resistant organismtime consumption indexMore Related Videos
Related Concept Videos
01:25Mechanism of Antibiotic Resistance in MRSA
115
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
115
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
373
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
373
01:25Clinical Significance of Antibiotic Resistance
43
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
43
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
72
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
72
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
01:28Pulmonary Tuberculosis V
888
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
888